Literature DB >> 19068461

[Survival chances of Hungarian cancer patients in the National Cancer Registry].

Gábor Tusnády1, István Gaudi, Lídia Rejto, Miklós Kásler, Zoltán Szentirmay.   

Abstract

The Hungarian National Cancer Registry (HNCR) was launched in August, 1999 by the National Cancer Institute. The main goal of HNCR is to determine the prevalence of different types of malignant cancers. A new method, period analysis was invented to determine survival chances of patients with malignant tumor. Based on period analysis we developed a new method by approximating survivals of Hungarian cancer patients with the help of Gompertz distribution. Our survival analysis was based on HNCR data of patients with cancer recognized between January 1, 2002 and December 31, 2005. These data are far enough from the time when HNCR started, thus they do not contain the initial errors, but also far enough from the present so their correction could be considered completed. In case of 21 malignant tumor locations for males and 23 ones for females we determined the parameters of the Gompertz distribution and based on the estimated parameters we estimated the expected survival probabilities for each specific tumor type and gender. In this study we have not used the TNM-based clinical stage or any other data of the patients contained by HNCR. Using the Gompertz model, the complete recovery of a cancer patient is always possible and the probability of recovery has a reliable estimate based on a short follow-up period only. We compared our results with five-year survival data of Canada, Italy, Norway and Finland and we did not find substantial differences. For both men and women, considering any specific location, the differences in survival among countries are much smaller than the difference between locations.

Entities:  

Mesh:

Year:  2008        PMID: 19068461     DOI: 10.1556/MOnkol.52.2008.4.2

Source DB:  PubMed          Journal:  Magy Onkol        ISSN: 0025-0244


  6 in total

1.  The disease burden of colorectal cancer in Hungary.

Authors:  Imre Boncz; Valentin Brodszky; Márta Péntek; István Agoston; Zsolt Nagy; Krisztián Kárpáti; Ildikó Kriszbacher; Péter Fuszek; László Gulácsi
Journal:  Eur J Health Econ       Date:  2010-01

2.  Retrospective analysis of clinicopathological characteristics and family history data of early-onset breast cancer: a single-institutional study of Hungarian patients.

Authors:  Lilla Madaras; Zsuzsanna Baranyák; Janina Kulka; Attila Marcell Szász; Attila Kovács; Phan Huong Lan; Borbála Székely; Magdolna Dank; Tibor Nagy; Orsolya Kiss; László Harsányi; Tamás Barbai; István Kenessey; Anna Mária Tőkés
Journal:  Pathol Oncol Res       Date:  2013-05-26       Impact factor: 3.201

Review 3.  Alternatives for the intensive follow-up after curative resection of colorectal cancer. Potential novel biomarkers for the recommendations.

Authors:  Enikő Orosz; István Ember; Katalin Gombos; László Tóth; Ádám Tarpay; Ákos Pap; Szabolcs Ottó
Journal:  Pathol Oncol Res       Date:  2013-07-19       Impact factor: 3.201

4.  Lung cancer drug therapy in Hungary - 3-year experience.

Authors:  Judit Moldvay; György Rokszin; Zsolt Abonyi-Tóth; Lajos Katona; Katalin Fábián; Gábor Kovács
Journal:  Onco Targets Ther       Date:  2015-05-13       Impact factor: 4.147

5.  Comparison of Cancer Survival Trends in Hungary in the Periods 2001-2005 and 2011-2015 According to a Population-Based Cancer Registry.

Authors:  István Kenessey; Georgina Szőke; Mária Dobozi; István Szatmári; András Wéber; György Fogarassy; Péter Nagy; Miklós Kásler; Csaba Polgár; Ágnes Vathy-Fogarassy
Journal:  Pathol Oncol Res       Date:  2022-09-06       Impact factor: 2.874

6.  Deuterium depleted water effects on survival of lung cancer patients and expression of Kras, Bcl2, and Myc genes in mouse lung.

Authors:  Zoltán Gyöngyi; Ferenc Budán; István Szabó; István Ember; István Kiss; Krisztina Krempels; Ildikó Somlyai; Gábor Somlyai
Journal:  Nutr Cancer       Date:  2013       Impact factor: 2.900

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.